XJPX7133
Market cap55mUSD
Jan 16, Last price
1,214.00JPY
1D
0.00%
1Q
2.02%
IPO
-40.49%
Name
Hyuga Primary Care Co Ltd
Chart & Performance
Profile
HYUGA PRIMARY CARE Co.,Ltd. provides home-visit pharmacies, nursing, and care planning services in Japan. The company offers know-how, systems, human resources, and sales for home visiting pharmacy operations to small and medium-sized pharmacy operators; lends Fam Care, an home visit support information system; On-call system support; and guidance on home palliative care. It also provides Tai Support, a nursing facility search site that offers medical social workers with information on senior housing with services, paid nursing homes, group homes, etc.; Mimamori ICT Robot Terminal, a wearable device for nursing care facilities; operates a home visiting pharmacy that delivers prescription drugs directly to patients; and engages in the primary care home business. The company was formerly known as Hyuga Pharmacy Co., Ltd. and changed its name to HYUGA PRIMARY CARE Co.,Ltd. in October 2020. HYUGA PRIMARY CARE Co.,Ltd. was incorporated in 2007 and is based in Kasuga, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
Income | |||||
Revenues | 8,285,853 24.46% | 6,657,448 15.13% | 5,782,604 13.70% | ||
Cost of revenue | 6,404,126 | 6,111,892 | 5,245,662 | ||
Unusual Expense (Income) | |||||
NOPBT | 1,881,727 | 545,556 | 536,942 | ||
NOPBT Margin | 22.71% | 8.19% | 9.29% | ||
Operating Taxes | 213,811 | 151,170 | 158,802 | ||
Tax Rate | 11.36% | 27.71% | 29.58% | ||
NOPAT | 1,667,916 | 394,386 | 378,140 | ||
Net income | 441,027 15.19% | 382,876 16.57% | 328,454 238.12% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | (281,037) | 27,993 | 134,345 | ||
BB yield | 1.93% | -0.15% | -0.52% | ||
Debt | |||||
Debt current | 487,363 | 115,699 | 136,400 | ||
Long-term debt | 2,478,803 | 193,569 | 193,814 | ||
Deferred revenue | (8,368) | (5,534) | |||
Other long-term liabilities | 100,194 | 41,676 | 29,951 | ||
Net debt | 2,016,757 | (454,420) | (414,607) | ||
Cash flow | |||||
Cash from operating activities | 706,642 | 342,252 | 484,597 | ||
CAPEX | (194,000) | (239,666) | (255,675) | ||
Cash from investing activities | (1,125,097) | (383,393) | (320,255) | ||
Cash from financing activities | 538,778 | (110,728) | 16,927 | ||
FCF | (1,032,246) | 37,145 | 315,345 | ||
Balance | |||||
Cash | 688,010 | 567,688 | 719,557 | ||
Long term investments | 261,399 | 196,000 | 25,264 | ||
Excess cash | 535,116 | 430,816 | 455,691 | ||
Stockholders' equity | 1,597,709 | 1,140,130 | 743,257 | ||
Invested Capital | 4,001,088 | 1,252,863 | 856,643 | ||
ROIC | 63.49% | 37.39% | 49.17% | ||
ROCE | 39.06% | 32.24% | 40.74% | ||
EV | |||||
Common stock shares outstanding | 7,442 | 7,534 | 7,582 | ||
Price | 1,956.00 -19.37% | 2,426.00 -29.37% | 3,435.00 | ||
Market cap | 14,556,118 -20.36% | 18,277,394 -29.82% | 26,044,311 | ||
EV | 16,572,875 | 17,822,974 | 25,629,704 | ||
EBITDA | 2,071,530 | 636,745 | 615,801 | ||
EV/EBITDA | 8.00 | 27.99 | 41.62 | ||
Interest | 9,740 | 2,032 | 2,570 | ||
Interest/NOPBT | 0.52% | 0.37% | 0.48% |